静脉注射促甲状腺素释放激素治疗反应性抑郁症的双盲试验。
A double-blind trial of intravenous thyrotrophin-releasing hormone in the treatment of reactive depression.
作者信息
Evans L E, Hunter P, Hall R, Johnston M, Roy V M
出版信息
Br J Psychiatry. 1975 Sep;127:227-30. doi: 10.1192/bjp.127.3.227.
PMID:810198
Abstract
In a double-blind trial 600 mug. of thyrotrophin-releasing hormone (TRH) was compared with placebo given daily for four days to two groups of ten patients. There was no significant difference between the antidepressant effects of TRH and placebo.
摘要
在一项双盲试验中，将两组各10名患者，连续四天每日给予600微克促甲状腺激素释放激素（TRH）或安慰剂。TRH与安慰剂的抗抑郁效果无显著差异。
Zotero 插件